Spots Global Cancer Trial Database for triapine
Every month we try and update this database with for triapine cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| 3-AP and Gemcitabine in Treating Patients With Refractory Metastatic Breast Cancer | NCT00095888 | Male Breast Can... Recurrent Breas... Stage IV Breast... | triapine gemcitabine hyd... laboratory biom... pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
| 3-AP and Gemcitabine in Treating Patients With Metastatic Non-Small Cell Lung Cancer | NCT00064064 | Lung Cancer | gemcitabine hyd... triapine | 18 Years - | National Cancer Institute (NCI) | |
| Testing the Addition of an Anti-cancer Drug, Triapine, to the Usual Radiation-Based Treatment (Lutetium Lu 177 Dotatate) for Neuroendocrine Tumors | NCT04234568 | Metastatic Dige... Metastatic Neur... | Biospecimen Col... Computed Tomogr... Lutetium Lu 177... Magnetic Resona... Triapine | 18 Years - | National Cancer Institute (NCI) | |
| Irinotecan and 3-AP in Treating Patients With Metastatic or Unresectable Solid Tumors | NCT00084877 | Unspecified Adu... | triapine irinotecan hydr... laboratory biom... pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
| 3-AP and Cisplatin in Treating Patients With Recurrent or Persistent Platinum-Resistant Ovarian Epithelial or Primary Peritoneal Cancer | NCT00081276 | Primary Periton... Recurrent Ovari... Stage III Ovari... Stage IV Ovaria... | triapine cisplatin laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Phase I Study of Intravenous Triapine (IND # 68338) in Combination With Pelvic Radiation Therapy With or Without Weekly Intravenous Cisplatin Chemotherapy for Locally Advanced Cervical, Vaginal, or Pelvic Gynecologic Malignancies | NCT00335998 | Recurrent Cervi... Recurrent Ovari... Recurrent Vagin... Recurrent Vulva... Stage III Vagin... Stage IIIA Cerv... Stage IIIA Ovar... Stage IIIA Vulv... Stage IIIB Cerv... Stage IIIB Ovar... Stage IIIB Vulv... Stage IIIC Ovar... Stage IIIC Vulv... Stage IV Ovaria... Stage IVA Cervi... Stage IVA Vagin... Stage IVB Cervi... Stage IVB Vagin... | triapine laboratory biom... external beam r... brachytherapy cisplatin pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
| Triapine, Cisplatin, and Radiation Therapy in Treating Patients With Cervical Cancer or Vaginal Cancer | NCT00941070 | Recurrent Cervi... Recurrent Vagin... Stage IB Cervic... Stage II Vagina... Stage IIA Cervi... Stage IIB Cervi... Stage III Cervi... Stage III Vagin... Stage IVA Cervi... Stage IVA Vagin... Stage IVB Cervi... Stage IVB Vagin... Therapy-related... | triapine cisplatin external beam r... quality-of-life... questionnaire a... fludeoxyglucose... positron emissi... computed tomogr... | 18 Years - | National Cancer Institute (NCI) | |
| 3-AP and Gemcitabine as Second-Line Therapy in Treating Patients With Stage III or Stage IV Recurrent Non-Small Cell Lung Cancer | NCT00077415 | Lung Cancer | gemcitabine hyd... triapine | 18 Years - | National Cancer Institute (NCI) | |
| 3-AP Plus Cisplatin in Treating Patients With Recurrent or Metastatic Adenocarcinoma of the Esophagus or Gastroesophageal Junction | NCT00077545 | Adenocarcinoma ... Recurrent Esoph... Stage IV Esopha... | triapine cisplatin | 18 Years - | National Cancer Institute (NCI) | |
| 3-AP Plus Cisplatin and Paclitaxel in Treating Patients With Advanced or Metastatic Cancer | NCT00016874 | Unspecified Adu... | cisplatin paclitaxel triapine | 18 Years - | National Cancer Institute (NCI) | |
| 3-AP and Gemcitabine as Second-Line Therapy in Treating Patients With Stage III or Stage IV Recurrent Non-Small Cell Lung Cancer | NCT00077415 | Lung Cancer | gemcitabine hyd... triapine | 18 Years - | National Cancer Institute (NCI) | |
| 3-AP and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic Cancer | NCT00064051 | Pancreatic Canc... | gemcitabine hyd... triapine | 18 Years - | National Cancer Institute (NCI) | |
| Testing the Effectiveness of an Anti-cancer Drug, Triapine, When Used With Targeted Radiation-based Treatment (Lutetium Lu 177 Dotatate), Compared to Lutetium Lu 177 Dotatate Alone for Metastatic Neuroendocrine Tumors | NCT05724108 | Metastatic Neur... | Biospecimen Col... Computed Tomogr... Lutetium Lu 177... Magnetic Resona... Triapine | 18 Years - | National Cancer Institute (NCI) | |
| Triapine in Combination With Temozolomide for the Treatment of Patients With Recurrent Glioblastoma | NCT06410248 | Recurrent Gliob... Recurrent WHO G... Recurrent WHO G... Recurrent WHO G... | Biospecimen Col... Magnetic Resona... Questionnaire A... Resection Temozolomide Triapine | 18 Years - | Northwestern University | |
| Testing the Effectiveness of an Anti-cancer Drug, Triapine, When Used With Targeted Radiation-based Treatment (Lutetium Lu 177 Dotatate), Compared to Lutetium Lu 177 Dotatate Alone for Metastatic Neuroendocrine Tumors | NCT05724108 | Metastatic Neur... | Biospecimen Col... Computed Tomogr... Lutetium Lu 177... Magnetic Resona... Triapine | 18 Years - | National Cancer Institute (NCI) | |
| Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers | NCT02466971 | Advanced Vagina... Advanced Vagina... Advanced Vagina... Cervical Adenoc... Cervical Adenos... Cervical Squamo... Stage IB2 Cervi... Stage II Cervic... Stage II Vagina... Stage IIA Cervi... Stage IIB Cervi... Stage III Vagin... Stage IIIB Cerv... Stage IV Vagina... Stage IVA Cervi... Stage IVA Vagin... Unresectable Va... Vaginal Adenoca... Vaginal Adenosq... Vaginal Carcino... Vaginal Squamou... | Brachytherapy Cisplatin External Beam R... Intensity-Modul... Laboratory Biom... Radiation Thera... Triapine | 18 Years - | National Cancer Institute (NCI) | |
| 3-AP and Radiation Therapy in Treating Patients With Stage III Pancreatic Cancer That Cannot Be Removed By Surgery | NCT00288093 | Pancreatic Aden... Stage III Pancr... | 3-Dimensional C... Triapine | 18 Years - | National Cancer Institute (NCI) | |
| Triapine and Gemcitabine Hydrochloride in Gallbladder Cancer | NCT00075504 | Stage II Gallbl... Stage IIIA Gall... Stage IIIB Gall... Stage IVA Gallb... Stage IVB Gallb... | triapine gemcitabine | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy in Treating Patients With Advanced Cancer | NCT00024323 | Unspecified Adu... | cisplatin triapine | 18 Years - | National Cancer Institute (NCI) | |
| 3-AP in Treating Patients With Advanced Cancer | NCT00006218 | Unspecified Adu... | triapine | 18 Years - | National Cancer Institute (NCI) | |
| Triapine and Gemcitabine Hydrochloride in Gallbladder Cancer | NCT00075504 | Stage II Gallbl... Stage IIIA Gall... Stage IIIB Gall... Stage IVA Gallb... Stage IVB Gallb... | triapine gemcitabine | 18 Years - | National Cancer Institute (NCI) | |
| Triapine and Gemcitabine Hydrochloride in Gallbladder Cancer | NCT00075504 | Stage II Gallbl... Stage IIIA Gall... Stage IIIB Gall... Stage IVA Gallb... Stage IVB Gallb... | triapine gemcitabine | 18 Years - | National Cancer Institute (NCI) | |
| 3-AP in Treating Patients With Advanced Prostate Cancer | NCT00054015 | Prostate Cancer | triapine | 18 Years - | National Cancer Institute (NCI) | |
| Testing the Response to the Anti-cancer Drug, Triapine, in Uterine Cancers Using Markers From the Tissue at the Time of Hysterectomy | NCT04494113 | Endometrial Ser... | Biopsy Biospecimen Col... Resection Triapine | 18 Years - | National Cancer Institute (NCI) | |
| 3-AP and Gemcitabine in Treating Patients With Recurrent, Unresectable, or Metastatic Pancreatic Cancer | NCT00078975 | Pancreatic Canc... | gemcitabine hyd... triapine | 18 Years - 120 Years | University Health Network, Toronto | |
| 3-AP in Treating Patients With Advanced or Metastatic Solid Tumors | NCT00390052 | Unspecified Adu... | triapine pharmacological... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Testing the Response to the Anti-cancer Drug, Triapine, in Uterine Cancers Using Markers From the Tissue at the Time of Hysterectomy | NCT04494113 | Endometrial Ser... | Biopsy Biospecimen Col... Resection Triapine | 18 Years - | National Cancer Institute (NCI) | |
| Triapine and Gemcitabine Hydrochloride in Gallbladder Cancer | NCT00075504 | Stage II Gallbl... Stage IIIA Gall... Stage IIIB Gall... Stage IVA Gallb... Stage IVB Gallb... | triapine gemcitabine | 18 Years - | National Cancer Institute (NCI) | |
| 3-Aminopyridine-2-carboxaldehyde Thiosemicarbazone in Treating Patients With Solid Tumors | NCT00004213 | Unspecified Adu... | triapine | 18 Years - | National Cancer Institute (NCI) | |
| 3-AP and Gemcitabine in Treating Patients With Recurrent, Unresectable, or Metastatic Pancreatic Cancer | NCT00078975 | Pancreatic Canc... | gemcitabine hyd... triapine | 18 Years - 120 Years | University Health Network, Toronto | |
| Triapine as First-Line or Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas | NCT00085371 | Acinar Cell Ade... Duct Cell Adeno... Recurrent Pancr... Stage III Pancr... Stage IV Pancre... | triapine | 18 Years - | National Cancer Institute (NCI) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
